Cargando…
For debate: substituting placebo controls in long-term Alzheimer's prevention trials
INTRODUCTION: Novel compounds with potential to attenuate or stop the progression of Alzheimer's disease (AD) from its presymptomatic stage to dementia are being tested in man. The study design commonly used is the long-term randomized, placebo-controlled trial (RPCT), meaning that many patient...
Autores principales: | Spiegel, René, Berres, Manfred, Miserez, André R, Monsch, Andreas U |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3226271/ https://www.ncbi.nlm.nih.gov/pubmed/21418632 http://dx.doi.org/10.1186/alzrt68 |
Ejemplares similares
-
Using historical data to facilitate clinical prevention trials in Alzheimer disease? An analysis of longitudinal MCI (mild cognitive impairment) data sets
por: Berres, Manfred, et al.
Publicado: (2021) -
Establishing robust cognitive dimensions for characterization and differentiation of patients with Alzheimer's disease, mild cognitive impairment, frontotemporal dementia and depression
por: Beck, Irene R, et al.
Publicado: (2014) -
The 12 Years Preceding Mild Cognitive Impairment Due to Alzheimer’s Disease: The Temporal Emergence of Cognitive Decline
por: Mistridis, Panagiota, et al.
Publicado: (2015) -
Cats and Apples: Semantic Fluency Performance for Living Things Identifies Patients with Very Early Alzheimer’s Disease
por: Krumm, Sabine, et al.
Publicado: (2020) -
The Montreal Cognitive Assessment: Normative Data from a German-Speaking Cohort and Comparison with International Normative Samples
por: Thomann, Alessandra E., et al.
Publicado: (2018)